Concurrent drug eluting/bare metal stent implantation during percutaneous coronary intervention in target vessel: Outcomes and 1-year follow-up

Clinical Research in Cardiology

Volumn 101, Issue 4, 2012, Pages 281-288

  Cuneo, Alessandro ^a,b   Bramlage, Peter ^c   Hochadel, Matthias ^d   Senges, Jochen ^d   Nienaber, Christoph ^e   Kuck, Karl Heinz ^a   Tebbe, Ulrich ^b  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b KLINIKUM LIPPE DETMOLD   (Germany)

^c Institut fur Pharmakologie und Praventive Medizin   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Bare metal stent; Concurrent BMS DES coronary artery stenting; Drug eluting stent

Indexed keywords

ACUTE CORONARY SYNDROME; AGE; AGED; ARTICLE; BARE METAL STENT; BLEEDING; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEMODIALYSIS; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTOR VARIABLE; RECURRENT DISEASE; REVASCULARIZATION; SMOKING; STROKE; TUMOR VOLUME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; REGISTRIES; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 84860836512     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0390-4     Document Type: Article

References (23)

1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ et al (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315-1323 (Pubitemid 37186209)
2. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R et al (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221-231 (Pubitemid 38067635)
3. Ryan J, Linde-Zwirble W, Engelhart L, Cooper L, Cohen DJ (2009) Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drugeluting stent eras: results from the US Medicare program. Circulation 119:952-961
4. Ryan J, Cohen DJ (2006) Are drug-eluting stents cost-effective? It depends on whom you ask. Circulation 114:1736-1743 (discussion 1744) (Pubitemid 44607122)
5. Kaya E, Cuneo A, Hochadel M, Junger C, Stepper W, Bramlage P, Kuck KH, Nienaber CA et al (2011) Impact of chronic kidney disease on the prognosis of patients undergoing percutaneous coronary interventions using drug-eluting stents. Clin Res Cardiol 100:1103-1109
6. Bauer T, Nienaber CA, Akin I, Kuck KH, Hochadel M, Senges J, Fetsch T, Tebbe U et al (2011) Comparison between on-label versus off-label use of drug-eluting coronary stents in clinical practice: results from the German DES.DE-Registry. Clin Res Cardiol 100:701-709
7. Sherif MA, Nienaber CA, Toelg R, Abdel-Wahab M, Geist V, Schneider S, Senges J, Kuck KH et al (2011) Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre German Drug-Eluting Stent Registry (DES.DE). Clin Res Cardiol 100:413-423
8. Akin I, Bufe A, Schneider S, Reinecke H, Eckardt L, Richardt G, Burska D, Senges J et al (2010) Clinical outcomes in diabetic and non-diabetic patients with drug-eluting stents: results from the first phase of the prospective multicenter German DES.DE registry. Clin Res Cardiol 99:393-400
9. Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich S, Stumpf J et al (2009) Clinical outcomes after sirolimus-eluting, paclitaxel-eluting and bare-metal stents in a real world setting (from the first phase of the prospective multicenter German DES.DE Registry). Am J Cardiol 104:1362-1369
10. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA et al (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344-2351 (Pubitemid 46685903)
11. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK et al (2007) Universal definition of myocardial infarction. Circulation 116:2634-2653 (Pubitemid 350182388)
12. Salwan R, Singhania D, Agarwal P, Chandra P, Mathur A, Bhandari S, Kler TS, Seth A (2004) Hybrid stenting vs drugeluting stents for multivessel angioplasty. Eur Heart J 25(Suppl.): 314
13. Werner GS, Schwarz G, Prochnau D, Fritzenwanger M, Krack A, Betge S, Figulla HR (2006) Paclitaxel-eluting stents for the treatment of chronic total coronary occlusions: a strategy of extensive lesion coverage with drug-eluting stents. Catheter Cardiovasc Interv 67:1-9 (Pubitemid 43062598)
14. Burzotta F, Siviglia M, Altamura L, Trani C, Leone AM, Romagnoli E, Mazzari MA, Mongiardo R et al (2007) Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents. Am J Cardiol 99:364-368 (Pubitemid 46149556)
15. Chu WW, Rha SW, Kuchulakanti PK, Cheneau E, Torguson R, Pakala R, Pinnow EE, Pichard AD et al (2005) Selective versus exclusive use of sirolimus-eluting stent implantation in multivessel coronary artery disease. Catheter Cardiovasc Interv 65:473-477 (Pubitemid 41060747)
16. Bertrand OF, Faurie B, Larose E, Nguyen CM, Gleeton O, Dery JP, Noel B, Proulx G et al (2008) Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents. J Invasive Cardiol 20:99-104 (Pubitemid 351346280)
17. Roy P (2006) The clinical outcome of restricting drug-eluting stents to patients at highest risk of restenosis. EuroIntervention 2:238-243
18. Syed AI, Ben-Dor I, Li Y, Collins SD, Torguson R, Wakabayashi K, Gonzalez MA, Maluenda G et al (2011) Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention. EuroIntervention 6:1085-1090
19. Takano M, Murakami D, Mizuno K (2007) Overlapping hybrid stenting with a sirolimus-eluting stent and a bare metal stent. Int J Cardiol 118:e8-e10 (Pubitemid 46517703)
20. Fineschi M, Gori T, Pierli C, Casini S, Sinicropi G, Buti A, Del Pasqua A, Bravi A (2005) Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world. Can J Cardiol 21:1281-1285 (Pubitemid 43174609)
21. Aoki J, Kirtane AJ, Dangas GD, Lansky AJ, Morales A, Kimura M, Kim YH, Moussa I et al (2008) Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings. Am J Cardiol 101:58-62 (Pubitemid 350297201)
22. Mirabella F, Francaviglia B, Capodanno D, Di Salvo ME, Galassi AR, Ussia GP, Capranzano P, Tamburino C (2009) Treatment of multilesion coronary artery disease with simultaneous drugeluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results. J Invasive Cardiol 21:145-150
23. Alexopoulos D, Xanthopoulou I, Karantalis V, Mitropoulou G, Damelou A, Davlouros P (2011) Simultaneous drug-eluting and bare-metal stent implantation: long-term clinical outcome and findings of clinically indicated coronary angiography. Clin Cardiol 34:317-321